StudyGraphics #VisualAbstract: Pembrolizumab improves long-term survival in patients with stage III melanoma May 5, 2021 | Teddy Guo Facebook Twitter Pinterest WhatsApp Linkedin ReddIt Email Print Click to read the study in The Lancet Oncology. RELATED ARTICLESMORE FROM AUTHOR #VisualAbstract: Vitamin D3 supplementation may reduce disease recurrence in patients with stage II melanoma and low Breslow scores #VisualAbstract Patients with follicular lymphoma experience a plateau in therapy initiation rates during their first decade of observation after diagnosis Mixed vaccination with ChAdOx1-S followed by BNT162b2 induces a robust humoral immune response
